Naltrexone Reduced Reappraisal Distress in 38-Person Threat fMRI Trial
The endogenous opioid system has been a candidate target for novel anxiety treatments, but a 2026 placebo-controlled crossover fMRI study in 38 healthy volunteers ran opposite the hypothesis…
Read article